Evidence map

ReviewPharmacoEconomics1998

Clinical positioning of HMG-CoA reductase inhibitors in lipid management protocols.

M CzirakyPubMed ↗Publisher ↗

No numbers read from the abstract.

3 papers cite it

1998
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 10346426